Across more than 50 hospitals and nine EHRs, Lifepoint unified breast cancer screening and incidental findings, increased follow-up adherence, and drove downstream volumes.
patients with breast abnormalities identified for follow-up
improvement in annual screening adherence
total downstream services

THE CHALLENGE
Lifepoint Health had breast cancer screening programs running across its large network of community hospitals, spanning rural and non-rural areas and multiple EHRs. Lifepoint set out to establish a system-wide approach to catch all abnormal breast findings and ensure they made it to follow-up.

THE SOLUTION
From March 2023 to December 2025, Lifepoint went live with Eon Breast across 52 facilities. Lifepoint replaced the facility-by-facility approach with one centralized, standardized infrastructure that works across all nine EHRs and the PACS behind them.

THE RESULT
Comparing the same facilities before and after go-live, return rates rose across every category tracked. Biopsy completion after a suspicious (BI-RADS 4A) finding climbed from 60.2% to 87.8%, and annual screening improved almost 16 percentage points.
“A radiologist can flag something perfectly, and it still doesn’t help the patient if they never come back for the biopsy. That was the part we couldn’t see before. Now I can look at any facility in the network and tell you who’s overdue and whether somebody’s reached out to them.”
Tiffany Dean, Director, Healthy Person Program, Lifepoint Health